BioMark Diagnostics

BioMark Diagnostics Assets per Share

The Total Assets per Share of BioMark Diagnostics (BUX.CN) as of Oct 14, 2026 is 0.02 CAD. In the previous year, Total Assets per Share was 0.03 CAD — a change of -40.64% (lower).

Assets per Share

0.02CAD

YoY

-40.64%

Last updated:

Total Assets per Share of BioMark Diagnostics is 2026 0.02 CAD. Total Assets per Share of BioMark Diagnostics was 2025 0.03 CAD. It decreases by -40.64% lower compared to the previous year.

The BioMark Diagnostics Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2019
0.00 CAD
Jan 1, 2020
0.01 CAD
Jan 1, 2021
0.01 CAD
Jan 1, 2022
0.01 CAD
Jan 1, 2023
0.01 CAD
Jan 1, 2024
0.01 CAD
Jan 1, 2025
0.03 CAD
Jan 1, 2026
0.02 CAD
The BioMark Diagnostics Assets per Share history
YEARAssets per ShareYoY
0.02CAD-40.64%
0.03CAD+187.83%
0.01CAD+48.70%
0.01CAD-50.24%
0.01CAD+54.43%
0.01CAD+49.53%
0.01CAD+1,739.66%
0.00CAD-33.05%
0.00CAD+30.76%
0.00CAD+17.18%
0.00CAD-85.34%
0.00CAD—
Access this data via the Eulerpool API

BioMark Diagnostics Stock analysis

What does BioMark Diagnostics do? BioMark Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioMark Diagnostics stock

Total Assets per Share of BioMark Diagnostics is 0.02 CAD in 2026.

Total Assets per Share of BioMark Diagnostics changed from 0.03 CAD to 0.02 CAD, representing a -40.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share BioMark Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

Other — BioMark Diagnostics

All Key Metrics — BioMark Diagnostics